ArticleRMD open2017
Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study.
Article in RMD open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.Rheumatology international · 2022Pooled it
- Wearables for Measuring the Physical Activity and Sedentary Behavior of Patients With Axial Spondyloarthritis: Systematic Review.JMIR mHealth and uHealth · 2022Pooled it
- Treatment of back pain in active axial spondyloarthritis with serial locoregional water-filtered infrared A radiation: A randomized controlled trial.Journal of back and musculoskeletal rehabilitation · 2022Trial
- Artificial intelligence in healthcare faces regulatory challenges: balancing innovation with human oversight.EULAR rheumatology open · 2026Review
- Personalized physical activity recommendations for people with axial spondyloarthritis using wearable activity tracker data: an exploratory study.Rheumatology international · 2025Article
- How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.Current rheumatology reports · 2024Review
- [Wearables in rheumatology].Zeitschrift fur Rheumatologie · 2024Review
- Article
- Online physiotherapy for people with axial spondyloarthritis: quantitative and qualitative data from a cohort study.Rheumatology international · 2024Article
- Article
- Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial.Clinical rheumatology · 2023Article
- Smartphone Pedometer Sensor Application for Evaluating Disease Activity and Predicting Comorbidities in Patients with Rheumatoid Arthritis: A Validation Study.Sensors (Basel, Switzerland) · 2022Article
- Insights Into the Concept of Rheumatoid Arthritis Flare.Frontiers in medicine · 2022Review
- Wearable activity trackers and artificial intelligence in the management of rheumatic diseases : Where are we in 2021?Zeitschrift fur Rheumatologie · 2021Review
- Article
- Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience.Rheumatology advances in practice · 2021Article
- Fitness-Tracker Assisted Frailty-Assessment Before Transcatheter Aortic Valve Implantation: Proof-of-Concept Study.JMIR mHealth and uHealth · 2020Article
- Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?Sensors (Basel, Switzerland) · 2020Review
- Physical activity measured using wearable activity tracking devices associated with gout flares.Arthritis research & therapy · 2020Article
- Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore.European journal of rheumatology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe evolution of rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA) is marked by flares, although their frequency is unclear. Flares may impact physical activity. Activity can be assessed objectively using activity trackers. The objective was to assess longitudinally the frequency of flares and the association between flares and objective physical activity.
methodsThis prospective observational study (ActConnect) included patients with definite clinician-confirmed RA or axSpA, owning a smartphone. During 3 months, physical activity was assessed continuously by number of steps/day, using an activity tracker, and disease flares were self-assessed weekly using a specific flare question and, if relevant, the duration of the flare. The relationship between flares and physical activity for each week (time point) was assessed by linear mixed models.
resultsIn all, 170/178 patients (91 patients with RA and 79 patients with axSpA; 1553 time points) were analysed: mean age was 45.5±12.4 years, mean disease duration was 10.3±8.7 years, 60 (35.3%) were men and 90 (52.9%) received biologics. The disease was well-controlled (mean Disease Activity Score 28: 2.3±1.2; mean Bath Ankylosing Spondylitis Disease Activity Index score: 3.3±2.1). Patients self-reported flares in 28.2%±28.1% of the weekly assessments. Most flares (78.9%±31.4%) lasted ≤3 days. Persistent flares lasting more than 3 days were independently associated with less weekly physical activity (p=0.03), leading to a relative decrease of 12%-21% and an absolute decrease ranging from 836 to 1462 steps/day.
conclusionFlares were frequent but usually of short duration in these stable patients with RA and axSpA. Persistent flares were related to a moderate decrease in physical activity, confirming objectively the functional impact of patient-reported flares.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.